Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06231238

Balance Acceptance and Commitment Therapy for Long COVID

A Randomised Controlled Trial Assessing the Efficacy of Balance Acceptance and Commitment Therapy (ACT) for Long COVID.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
196 (estimated)
Sponsor
King's College London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomised controlled trial aims to investigate the efficacy of a psychological intervention for long COVID (LC) / post-COVID-19 syndrome (PCS) called Balance Acceptance and Commitment Therapy (Balance ACT). The primary objective of this trial is to investigate whether Balance-ACT improves quality of life over treatment as usual (i.e., self-help leaflet) in people with PCS/LC.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBalance Acceptance and Commitment TherapyBalance-ACT is an ACT-based psychological intervention specifically designed for people with PCS/LC. Balance-ACT will use ACT techniques and mindfulness and will focus on establishing a balance psychologically and physiologically and regulating homeostasis. More specifically, Balance ACT will aim to regulate behaviours such as sleep, stress and activity, which can subsequently have an impact on homeostasis and physiology. Balance-ACT will also encourage people to live a values-based life and set goals according to their values.

Timeline

Start date
2024-06-04
Primary completion
2026-04-14
Completion
2026-06-01
First posted
2024-01-30
Last updated
2026-02-11

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06231238. Inclusion in this directory is not an endorsement.